Bone-building drug which prevents fractures in people with osteoporosis approved for use in UK – here’s how it works

The drug was shown to reduce risk of arm and wrist fractures by 69%. Peter Porrini/ Shutterstock A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of fractures. Abaloparatide’s approvalContinue Reading

A July inflation figure on which annual rail fare rises have historically been based was 3.6% this year, the Office for National Statistics announced. That was last month’s Retail Prices Index (RPI), which until 2023 was used by Westminster governments to set the cap on annual increases in regulated faresContinue Reading